• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手指结构域和生长因子结构域在肝细胞清除组织型纤溶酶原激活物中的作用。

The role of the finger and growth factor domains in the clearance of tissue-type plasminogen activator by hepatocytes.

作者信息

Camani C, Kruithof E K

机构信息

Division of Hematology, University Hospital, Lausanne, Switzerland.

出版信息

J Biol Chem. 1995 Nov 3;270(44):26053-6. doi: 10.1074/jbc.270.44.26053.

DOI:10.1074/jbc.270.44.26053
PMID:7592802
Abstract

The relative contribution of the finger/growth factor domains of tissue-type plasminogen activator (t-PA) and of the other t-PA domains to the clearance of t-PA by hepatocytes was investigated. A recombinant finger/growth factor construct inhibited t-PA and t-PA/plasminogen activator inhibitor type-1 degradation with an IC50 of 1800 nM, whereas a t-PA mutant lacking the finger and growth factor domains inhibited degradation with an estimated IC50 of 1200 nM. In comparison the IC50 of t-PA was found to be approximately 10 nM. Clearance of t-PA by human or rat hepatoma cells was not inhibited by high concentrations of fucose (50 mM), which suggests that the fucose on Thr-61 is not involved in clearance by these cells. These results suggest that the binding of t-PA involves several low affinity binding sites located on distinct domains of the t-PA molecule.

摘要

研究了组织型纤溶酶原激活剂(t-PA)的指状/生长因子结构域以及其他t-PA结构域对肝细胞清除t-PA的相对贡献。一种重组指状/生长因子构建体抑制t-PA和t-PA/纤溶酶原激活剂抑制剂1型的降解,IC50为1800 nM,而缺乏指状和生长因子结构域的t-PA突变体抑制降解,估计IC50为1200 nM。相比之下,t-PA的IC50约为10 nM。高浓度岩藻糖(50 mM)不抑制人或大鼠肝癌细胞对t-PA的清除,这表明苏氨酸-61上的岩藻糖不参与这些细胞的清除。这些结果表明,t-PA的结合涉及位于t-PA分子不同结构域上的几个低亲和力结合位点。

相似文献

1
The role of the finger and growth factor domains in the clearance of tissue-type plasminogen activator by hepatocytes.手指结构域和生长因子结构域在肝细胞清除组织型纤溶酶原激活物中的作用。
J Biol Chem. 1995 Nov 3;270(44):26053-6. doi: 10.1074/jbc.270.44.26053.
2
Studies on the effect of fucosylated and non-fucosylated finger/growth-factor constructs on the clearance of tissue-type plasminogen activator mediated by the low-density-lipoprotein-receptor-related protein.岩藻糖基化和非岩藻糖基化的指状/生长因子构建体对由低密度脂蛋白受体相关蛋白介导的组织型纤溶酶原激活物清除作用的研究。
Eur J Biochem. 1998 Feb 1;251(3):804-11. doi: 10.1046/j.1432-1327.1998.2510804.x.
3
The role of plasminogen activator inhibitor type 1 in the clearance of tissue-type plasminogen activator by rat hepatoma cells.纤溶酶原激活物抑制剂1在大鼠肝癌细胞清除组织型纤溶酶原激活物中的作用
J Biol Chem. 1994 Feb 25;269(8):5770-5.
4
alpha-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells.α-岩藻糖介导的HepG2细胞对组织型纤溶酶原激活物的结合与降解
J Clin Invest. 1994 Feb;93(2):703-10. doi: 10.1172/JCI117023.
5
Demonstration of a specific clearance receptor for tissue-type plasminogen activator on rat Novikoff hepatoma cells.
J Biol Chem. 1992 Mar 25;267(9):6249-56.
6
Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor.通过化学交联鉴定大鼠肝癌细胞上组织型纤溶酶原激活物(t-PA)结合蛋白并对其进行部分特性分析。一种1型纤溶酶原激活物抑制剂非依赖性t-PA受体。
J Biol Chem. 1992 Aug 5;267(22):15595-602.
7
The receptor for tissue plasminogen activator (t-PA) in complex with its inhibitor, PAI-1, on human hepatocytes.组织型纤溶酶原激活物(t-PA)与其抑制剂纤溶酶原激活物抑制剂-1(PAI-1)在人肝细胞上形成的复合物的受体。
FEBS Lett. 1991 Jan 14;278(1):95-7. doi: 10.1016/0014-5793(91)80092-h.
8
Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells.组织型纤溶酶原激活物 - 1型纤溶酶原激活物抑制剂复合物与HepG2细胞结合所涉及的决定因素的鉴定。
J Biol Chem. 1990 Aug 25;265(24):14093-9.
9
Tyrosine 67 in the epidermal growth factor-like domain of tissue-type plasminogen activator is important for clearance by a specific hepatic receptor.组织型纤溶酶原激活剂的表皮生长因子样结构域中的酪氨酸67对于通过特定肝受体清除至关重要。
J Biol Chem. 1992 May 15;267(14):9668-77.
10
Interactions between tissue-type plasminogen activator and extracellular matrix-associated plasminogen activator inhibitor type 1 in the human hepatoma cell line HepG2.人肝癌细胞系HepG2中组织型纤溶酶原激活剂与细胞外基质相关的1型纤溶酶原激活剂抑制剂之间的相互作用。
J Biol Chem. 1989 Oct 25;264(30):18180-7.

引用本文的文献

1
Structural Biology and Protein Engineering of Thrombolytics.溶栓剂的结构生物学与蛋白质工程
Comput Struct Biotechnol J. 2019 Jul 2;17:917-938. doi: 10.1016/j.csbj.2019.06.023. eCollection 2019.